- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- EFB0027 (metformin delayed release), EFB0026 (metformin immediate-release)
- Drug
- Lead sponsor
- Elcelyx Therapeutics, Inc.
- Industry
- Eligibility
- 19 Years to 70 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 2
- States / cities
- Tempe, Arizona • Lincoln, Nebraska
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–6
of 6
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Acute Upper Respiratory Tract Infection
- Interventions
- Mucinex, Immediate-release Guaifenesin, Placebo
- Drug
- Lead sponsor
- Reckitt Benckiser LLC
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 2,810 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 43
- States / cities
- Hoover, Alabama • Bell Gardens, California • Harbor City, California + 38 more
- Conditions
- Healthy
- Interventions
- Treatment A: Canagliflozin tablet, Treatment A: Metformin IR tablets, Treatment B: Canagliflozin/metformin fixed dose combination tablets
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 19 Years to 55 Years
- Enrollment
- 74 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011
- U.S. locations
- 1
- States / cities
- Lincoln, Nebraska
- Conditions
- Depression - Major Depressive Disorder
- Interventions
- Pramipexole Immediate Release
- Drug
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Met DR, Met IR, Placebo
- Drug
- Lead sponsor
- Elcelyx Therapeutics, Inc.
- Industry
- Eligibility
- 25 Years and older
- Enrollment
- 571 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 134
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Tuscumbia, Alabama + 107 more
- Conditions
- Bioequivalence
- Interventions
- Canagliflozin and Metformin Immediate Release (IR) Fixed Dose Combination [FDC], Canagliflozin, Metformin
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 2 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014
- U.S. locations
- 1
- States / cities
- Lincoln, Nebraska